Necroptosis-related lncRNA signature predicts prognosis and immune response for cervical squamous cell carcinoma and endocervical adenocarcinomas.

Lin, Zhiheng; Zou, Jiani; Sui, Xiaohui; Yao, Shujuan; Lin, Lidong; Wang, Jiuling; Zhao, Junde

Lin, Zhiheng; Zou, Jiani; Sui, Xiaohui; Yao, Shujuan; Lin, Lidong; Wang, Jiuling; Zhao, Junde.

Afiliación

Lin Z; Shandong University of Traditional Chinese Medicine, Jinan, 250014, Shandong, China. linzhiheng2020@163.com.
Zou J; Shandong University of Traditional Chinese Medicine, Jinan, 250014, Shandong, China.
Sui X; Shandong University of Traditional Chinese Medicine, Jinan, 250014, Shandong, China.
Yao S; Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250014, Shandong, China.
Lin L; Shandong University of Traditional Chinese Medicine, Jinan, 250014, Shandong, China.
Wang J; Office of Medical Insurance Management, Qilu Hospital of Shandong University, Jinan, 250012, China. ayi-99@163.com.
Zhao J; Shandong University of Traditional Chinese Medicine, Jinan, 250014, Shandong, China. zhaojunde2020@163.com.

Sci Rep ; 12(1): 16285, 2022 09 29.

Article en En | MEDLINE | ID: mdl-36175606

Asunto(s)

Adenocarcinoma; Carcinoma de Células Escamosas; ARN Largo no Codificante; Neoplasias del Cuello Uterino; Femenino; Humanos; Carcinoma de Células Escamosas/genética; Inmunidad; Necroptosis/genética; Pronóstico; ARN Largo no Codificante/genética; Neoplasias del Cuello Uterino/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Adenocarcinoma / Neoplasias del Cuello Uterino / ARN Largo no Codificante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Sci Rep Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google